Jha Washington: The United States has so far given only 7.5 million doses of Covid antibody to India, which is not adequate, a top Indian-American Congressman stated while requesting the Biden Administration to do more. Congressman Raja Krishnamoorthi said this after securing the help of 116 members of the Congress on his ongoing endeavor to stretch US global vaccine aid drives to India and other nations. His statement has come on a day when the White House said it is eager to pursue partnership with India in the fight against coronavirus and wants to provide support, including vaccines.
I’m once again requesting President Biden and my colleagues in the Congress to come close and pass the NOVID Act into law to end this epidemic for good because, so long as pandemic continue in any nation, the entire globe faces the threat of new, vaccine-resistant mutants, Krishnamoorthi said in a statement. As we celebrate Indian Independence Day, we need to announce our independence from Covid by creating the global partnership necessary to develop and deliver the billions of vaccines necessary to truly bring this pandemic to a conclusion, he said.
Fulfilling those targets will demand the continued cooperation of the world’s leading democracies and creators of these life-saving antibodies, including the United States and India, Krishnamoorthi added. Under the NOVID Act, which Congressman Raja Krishnamoorthi, Senators Jeff Merkley and Elizabeth Warren initiated with Congresswoman Pramila Jayapal, the US will establish the Pandemic Preparedness and Response Program (PanPReP) to oversee the global welfare response to the pandemic.
PanPReP will harmonize efforts between the Department of State, USAID, CDC, FDA, BARDA, Health Resources and Services Administration, DOD, the Peace Corps, and the Department of Labor. The crusade will also be responsible for harmonizing the US Government response with international non-governmental organisations, development banks and civil society as well as foreign governments. After the pandemic, the motion will shift to shield against future pandemics by synchronizing a global disease surveillance network to notify and stop pandemic-potential infections before they spread furiously. The bill will authorise spending of USD 34 billionUSD 25 billion to scale producing capacity and produce 8 billion vaccine doses; USD8.5 billion to cover the cost of end-to-end delivery of enough antibody to vaccinate 60 per cent of the populations in 92 COVAX countries; and USD 500 million to organize a global disease surveillance network to save against future pandemics.